Literature DB >> 62180

Levamisole and agranulocytosis.

O Ruuskanen, M Remes, A L Mäkela, H Isomäki, A Toivanen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62180     DOI: 10.1016/s0140-6736(76)90916-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Levamisol-induced thrombocytopenia.

Authors:  A F El-Ghobarey; H A Capell
Journal:  Br Med J       Date:  1977-08-27

2.  Side effects of levamisole in children with nephrosis.

Authors:  J B Palcoux; P Niaudet; P Goumy
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

3.  Onset of leukaemia after levamisole treatment for nephrotic syndrome.

Authors:  F E Mackie; L P Roy; M Stevens
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

4.  Levamisole-induced reduction in seizure threshold: a possible role of nicotinic acetylcholine receptor-mediated pathway.

Authors:  Ashish K Rehni; Thakur Gurjeet Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-06       Impact factor: 3.000

Review 5.  Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

Authors:  P Chrisp; D McTavish
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

6.  Neutropenia during treatment of rheumatoid arthritis with levamisole.

Authors:  G T Williams; S A Johnson; P A Dieppe; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1978-08       Impact factor: 19.103

7.  A double-blind pediatric evaluation of levamisole in the prevention of recurrent upper respiratory tract infections.

Authors:  M Van Eygen; F Dils; J Gillerot; E Verschueren
Journal:  Eur J Pediatr       Date:  1979-06-28       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.